Company

Company. We are committed to bring advances in the Genomics arena to everyday’s health care and disease prevention.

Technology. Our technology solves DNA sequencing critical limitations allowing simultaneous genome and epigenome analysis.

Products: Aniling products are based on GEUS technology and provide a bolt-on workflow from library preparation to clinical report.

About Us

GEUS Technology

Aniling owns the GEUS technology, which unifies genetic and epigenetic sequencing and provides end-to-end solutions for the right treatment decisions in oncology. Based on GEUS, Aniling is developing a set of products for cancer diagnostic.

GEUS-CLL

The first Aniling product is the most comprehensive Chronic Lymphocytic Leukemia Next Generation Sequencing diagnostics panel. The GEUS-CLL delivers accurate staging and treatment decisions. Aniling S.L. provides the GEUS-CLL diagnostic test as a service to other laboratories and hospitals.

Latest News

World Cancer Day
News

World Cancer Day 2023

In 2 days, we will mark World Cancer Day. World Cancer Day is a global uniting initiative led by the Union for International Cancer Control (UICC). It aims to promote awareness …

RETOS 2017
News

Retos Colaboration 2017 project completion

Aniling completes the Retos Colaboración project with the development of a genetic and epigenetic test (GEUS-LB®) for the early detection of colorectal cancer  in a blood sample. The Aniling -led project uses patented GEUS …

Read Our Blog

Get in touch